Our data are thus indicative of a PLEKHA8P1-PLEKHA8 axis in modulating chemoresistance, with PLEKHA8P1 as a possible ceRNA for miRNAs that inhibit PLEKHA8, which in turn promotes tumor progression through Wnt/β-catenin signaling. The gene discussed is PLEKHA8P1; the disease is neoplasm.